Moderna's new lower-dose COVID-19 vaccine approved by FDA
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Jun 4, 2025
0
195









